Who invested in Tavo Biotherapeutics?
Tavo Biotherapeutics's investors include Pureos Bioventures, Polaris Partners, Tau Ventures and BioVenture. Pureos Bioventures led its latest round.
Who invested in Tavo Biotherapeutics
One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 5 months ago
Follow Tavo Biotherapeutics and see its new rounds in your feed. Start following
Funding summaryUpdated 5 Nov 2026
$17Mraised across 1 round since 2026, from 2 sources
- Latest round
- Series A, $17MJun 2026
- Led by
- Pureos Bioventures
- Investors
- 4 (1 led)
The rounds
- Jun 2026Series A$17M
Reported by Ventureburn and 1 other
Founders and team
From Tavo Biotherapeutics's own website: 3 on the team.
Everyone who backed them
BioVentureVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Tavo Biotherapeutics
How much has Tavo Biotherapeutics raised?
Tavo Biotherapeutics has raised $17M across 1 round since 2026.
When did Tavo Biotherapeutics last raise?
Tavo Biotherapeutics's most recent round was a Series A of $17M in Jun 2026, led by Pureos Bioventures.
What was Tavo Biotherapeutics's biggest round?
Its most recent round, $17M in Jun 2026, is also its largest on record.
Who backed Tavo Biotherapeutics first?
Tavo Biotherapeutics's first round on record, in Jun 2026, was backed by Pureos Bioventures, Polaris Partners and Tau Ventures and 1 others.
What stage is Tavo Biotherapeutics at?
Tavo Biotherapeutics's latest named round is a Series A, in Jun 2026.
Who led Tavo Biotherapeutics's rounds?
Pureos Bioventures led the Series A in 2026.
Companies like Tavo Biotherapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.